Drug Against Tuberculosis | OMICS International | Mycobacterial Diseases

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Drug Against Tuberculosis

Drug-resistant and multidrug-resistant (MDR-TB); resistant to at least isoniazid [INH] and rifampin [RMP]) strains of Mycobacterium tuberculosis are man-made problems mainly related to poor case management and lack of quality drugs. M. tuberculosis complex use several strategies to resist the action of antimicrobial agents. TB control activities require regular direct measurement of the absolute burden of disease to monitor trends and improve understanding of the epidemiology of TB in the target area. In many HBCs, notification systems do not record all cases and vital registration systems are either absent or of such poor quality and coverage that TB statistics is often unreliable. So far there was no latest report on the prevalence of MDR-TB in Ethiopia, especially in the study area, Amhara National Regional State (ANRS). This study aimed to determine the prevalence and associated factors of MDR-TB among presumptive MDR-TB cases in ANRS.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on May, 2021